Acute renal failure due to severe hyperuricemia is reported in a liver transplant recipient undergoing rescue therapy with FK506. Earlier treatment with cyclosporine had been complicated by gout and uric acid nephrolithiasis. Transplant recipients with symptomatic hyperuricemia on cyclosporine may be at particular risk for marked hyperuricemia when conversion to FK506 results in FK506 toxicity.